Search bioRxiv⌕ Search

Biology subjects

Mok, L.

Publications and source records attributed to Mok, L..

4 recordsLinked to original sources

PRISM : Peptide-specificity annotation of T-cell receptors with uncertainty quantification

Mapping T-cell receptor (TCR) sequences to their cognate peptide-major histocompatibility complex (pMHC) ligands underlies both basic immunology and T-cell target discovery, yet current models aimed at predicting TCR specificity are limited by sparse labels, viral-biased training data, and an inability to recognize receptors outside their training distribution. We present PRISM, an uncertainty-aware metric-learning framework for TCR{beta} sequence representation. PRISM embeds receptors into a peptide-organized latent space, returns top-k peptides by nearest-neighbor retrieval, and abstains on out-of-distribution receptors by modeling an intrinsic uncertainty that tracks annotation correctness. To offset the viral bias of public databases, PRISM augments training data with structure-guided synthetic receptors that diversify TCR sequences while preserving the energetics of the TCR-pMHC interface. Across a held-out set of 923 peptides and the independent IMMREP23 benchmark, PRISM matches or exceeds sequence-based models, with largest gains on rare epitopes. Finally, PRISM learns attention weights on TCR residues that concentrate on the CDR3{beta} salt-bridge and hydrophobic contacts central to peptide recognition, linking PRISMs positional focus to the biochemical properties of TCR-pMHC structures.

immunology↗

TRIOPS: A deep learning framework for prediction of T cell receptor-MHC binding specificity

T cell receptor (TCR) recognition is MHC-restricted, yet accurately predicting a TCRs restricting HLA allele remains an open problem. We present TRIOPS, a dual-branch convolutional model with soft cross-attention that predicts TCR-MHC restriction from amino acid sequence alone. TRIOPS uses cross-reactivity-aware negative sampling by HLA pseudosequence similarity to reduce allele-boundary label noise, extending prediction to alleles absent from training. TRIOPS reaches a held-out AUC of 0.97 for paired TCR{beta} and 0.92 for TCR{beta}-only inputs, generalizes to unseen receptors and HLA alleles, and after locus-specific calibration, assigns TCR clonotypes to their likeliest restricting allele across an individuals HLA genotype. In TCGA tumors, TCR repertoires preferentially engage the expression-lost allele at HLA-A and HLA-B and the retained allele at HLA-C, recapitulating from bulk tumor RNA-seq the allele specific HLA loss previously linked to immune escape.

immunology↗

A rare HSC-derived megakaryocyte progenitor accumulates via enhanced survival and contributes to exacerbated thrombopoiesis upon aging

Distinct routes of cellular production from hematopoietic stem cells (HSCs) have defined our current view of hematopoiesis. Recently, we challenged classical views of platelet generation, demonstrating that megakaryocyte progenitors (MkPs), and ultimately platelets, can be specified via an alternate and additive route of HSC-direct specification specifically during aging. This "shortcut" pathway generates hyperactive platelets likely to contribute to age-related platelet-mediated morbidities. Here, we used single-cell RNA/CITEseq to demonstrate that these age-unique, non-canonical (nc)MkPs can be prospectively defined and experimentally isolated from wild type mice. Surprisingly, this revealed that a rare population of ncMkPs also exist in young mice. Young and aged ncMkPs are functionally distinct from their canonical (c)MkP counterparts, with aged ncMkPs paradoxically and uniquely exhibiting enhanced survival and platelet generation capacity. We further demonstrate that aged HSCs generate significantly more ncMkPs than their younger counterparts, yet this is accomplished without strict clonal restriction. Together, these findings reveal significant phenotypic, functional, and aging-dependent heterogeneity among the MkP pool and uncover unique features of megakaryopoiesis throughout life, potentially offering cellular and molecular targets for mitigation of age-related adverse thrombotic events.

cell biology↗

Non-canonical RNA substrates of Drosha lack many of the conserved features found in primary microRNA stem-loops

The RNase III enzyme Drosha has a central role in microRNA (miRNA) biogenesis, where it is required to release the stem-loop intermediate from primary (pri)-miRNA transcripts. However, it can also cleave stem-loops embedded within messenger (m)RNAs. This destabilizes the mRNA causing target gene repression and appears to occur primarily in stem cells. While pri-miRNA stem-loops have been extensively studied, such non-canonical substrates of Drosha have yet to characterized in detail. In this study, we employed high-throughput sequencing to capture all polyA-tailed RNAs that are cleaved by Drosha in mouse embryonic stem cells (ESCs) and compared the features of non-canonical versus miRNA stem-loop substrates. First, mRNA substrates are less efficiently processed than miRNA stem-loops. Sequence and structural analyses revealed that these mRNA substrates are also less stable and more likely to fold into alternative structures than miRNA stem-loops. Moreover, they lack the sequence and structural motifs found in miRNAs stem-loops that are required for precise cleavage. Notably, we discovered a non-canonical Drosha substrate that is cleaved in an inverse manner, which is a process that is normally inhibited by features in miRNA stem-loops. Our study thus provides valuable insights into the recognition of non-canonical targets by Drosha.

molecular biology↗